Home
Categories
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
Sequire Spotlight
Events

Home
Categories
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
Sequire Spotlight
Events

Acurx Announces First Patient Enrolled in Phase 2b Clinical Trial of its Lead Antibiotic for Treatment of Clostridioides difficile Infection (CDI)

December 6, 2021

Biotechnology

Related Post

Nutriband Inc. Announces $8.4M Private Placement

April 19, 2024
Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million

April 18, 2024
Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 Study

April 16, 2024
SciSparc to Acquire AutoMax

April 11, 2024

Microcaps.com is a trademark of SRAX, Inc.

Privacy Policy
Cookie Policy
Contact Us

About SRAX
About Sequire

We use cookies to improve your experience on our site, to show you personalized advertising, and as otherwise described in our Cookie Policy . To find out more, read our Privacy Policy and our Cookie Policy.